Drug intelligence / Profile preview

Advanced - Supplemented Zimu Dan

Development stage: Preclinical
Administration: Oral

Overview

Advanced - Supplemented Zimu Dan is a Traditional Chinese Medicine (TCM) formula. It is being investigated in a clinical trial for the treatment of chronic hepatitis B, specifically targeting the TCM syndrome characterized by "Yin deficiency of liver and kidney." This formula is part of a set of advanced TCM interventions developed by renowned TCM doctors in China.

Other names: Supplemented Zimu Dan

Beyond the preview

Go deeper on Advanced - Supplemented Zimu Dan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced - Supplemented Zimu Dan.

Explore the full profile